Exclusive-Drugmakers set to raise U.S. prices on at least 500 drugs in January
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) -Drugmakers including Pfizer, Sanofi and Takeda...
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) -Drugmakers including Pfizer, Sanofi and Takeda...
By Brendan Pierson (Reuters) – Bayer has won a trial in a lawsuit brought by...
By Ross Kerber, Simon Jessop and Peter Henderson BOSTON/DUBAI/SAN FRANCISCO (Reuters) – A growing list...
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson on Tuesday forecast revenue growth...
By Tom Hals (Reuters) – A Missouri jury ordered Bayer to pay $1.56 billion to...
By Bhanvi Satija and Michael Erman (Reuters) – Pfizer on Tuesday urged investors to focus...
By Michael Erman and Ahmed Aboulenein NEW YORK/WASHINGTON (Reuters) – Americans have started rolling up...
By Ahmed Aboulenein and Michael Erman (Reuters) -Around 4 million Americans received the updated COVID-19...
By Brendan Pierson (Reuters) -The U.S. government’s Medicare health insurance program can begin negotiating prices...
By Natalie Grover and Martin Coulter LONDON (Reuters) – Major drugmakers are using artificial intelligence...